Company page

Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc. (ticker: KLDO) is a public company based in the United States, with a market capitalization of approximately $4.26 billion. The company focuses on developing innovative therapies aimed at improving human health through the modulation of the microbiome. Kaleido is actively engaged in advancing its pipeline of product candidates to address various health conditions.